{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:17:43Z","timestamp":1791807463388,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BU3075\/2\u20111"],"award-info":[{"award-number":["BU3075\/2\u20111"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KI2434\/1-2"],"award-info":[{"award-number":["KI2434\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To investigate the diagnostic feasibility of a shortened breast PET\/MRI protocol in breast cancer patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Altogether 90 women with newly diagnosed T1<jats:sub>tumor-staged<\/jats:sub> (T1<jats:sub>ts<\/jats:sub>) and T2<jats:sub>tumor-staged<\/jats:sub> (T2<jats:sub>ts<\/jats:sub>) breast cancer were included in this retrospective study. All underwent a dedicated comprehensive breast [<jats:sup>18<\/jats:sup>F]FDG-PET\/MRI. List-mode PET data were retrospectively reconstructed with 20, 15, 10, and 5\u00a0min for each patient to simulate the effect of reduced PET acquisition times. The SUV<jats:sub>max\/mean<\/jats:sub> of all malign breast lesions was measured. Furthermore, breast PET data reconstructions were analyzed regarding image quality, lesion detectability, signal-to-noise ratio (SNR), and image noise (IN). The simultaneously acquired comprehensive MRI protocol was then shortened by retrospectively removing sequences from the protocol. Differences in malignant breast lesion detectability between the original and the fast breast MRI protocol were evaluated lesion-based. The 20-min PET reconstructions and the original MRI protocol served as reference.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In all PET reconstructions, 127 congruent breast lesions could be detected. Group comparison and T1<jats:sub>ts<\/jats:sub> vs. T2<jats:sub>ts<\/jats:sub> subgroup comparison revealed no significant difference of subjective image quality between 20, 15, 10, and 5\u00a0min acquisition times. SNR of qualitative image evaluation revealed no significant difference between different PET acquisition times. A slight but significant increase of IN with decreasing PET acquisition times could be detected. Lesion SUV<jats:sub>max<\/jats:sub> group comparison between all PET acquisition times revealed no significant differences. Lesion-based evaluation revealed no significant difference in breast lesion detectability between original and fast breast MRI protocols.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Breast [<jats:sup>18<\/jats:sup>F]FDG-PET\/MRI protocols can be shortened from 20 to below 10\u00a0min without losing essential diagnostic information.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p><jats:italic>\u2022 A highly accurate breast cancer evaluation is possible\u00a0by the shortened breast [<\/jats:italic><jats:sup><jats:italic>18<\/jats:italic><\/jats:sup><jats:italic>F]FDG-PET\/MRI examination protocol.<\/jats:italic><\/jats:p>\n                <jats:p><jats:italic>\u2022 Significant time saving at breast [<\/jats:italic><jats:sup><jats:italic>18<\/jats:italic><\/jats:sup><jats:italic>F]FDG-PET\/MRI protocol could increase patient satisfaction and patient throughput for breast cancer patients at PET\/MRI.<\/jats:italic><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00330-023-09580-6","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T16:03:47Z","timestamp":1681315427000},"page":"6179-6188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Towards a fast PET\/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-3430","authenticated-orcid":false,"given":"Kai","family":"Jannusch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike E.","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Martin","family":"Bruckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna","family":"Morawitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Dietzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey L.","family":"Pomykala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Bittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svjetlana","family":"Mohrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Umutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Antoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald H.","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"9580_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"9580_CR2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2022.01.003","author":"NM Bruckmann","year":"2022","unstructured":"Bruckmann NM, Morawitz J, Fendler WP et al (2022) A role of PET\/MR in breast cancer? Semin Nucl Med. https:\/\/doi.org\/10.1053\/j.semnuclmed.2022.01.003","journal-title":"Semin Nucl Med"},{"key":"9580_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.euf.2021.01.016","volume":"7","author":"V Murthy","year":"2021","unstructured":"Murthy V, Sonni I, Jariwala N et al (2021) The role of PSMA PET\/CT and PET\/MRI in the initial staging of prostate cancer. Eur Urol Focus 7:258\u2013266","journal-title":"Eur Urol Focus"},{"key":"9580_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2214\/AJR.14.13181","volume":"204","author":"L Heacock","year":"2015","unstructured":"Heacock L, Weissbrot J, Raad R et al (2015) PET\/MRI for the evaluation of patients with lymphoma: initial observations. AJR Am J Roentgenol 204:842\u2013848","journal-title":"AJR Am J Roentgenol"},{"key":"9580_CR5","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1007\/s00259-018-4102-4","volume":"45","author":"J Kirchner","year":"2018","unstructured":"Kirchner J, Grueneisen J, Martin O et al (2018) Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET\/MRI. Eur J Nucl Med Mol Imaging 45:2328\u20132337","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9580_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.2019182947","volume":"292","author":"RM Mann","year":"2019","unstructured":"Mann RM, Cho N, Moy L (2019) Breast MRI: state of the art. Radiology 292:520\u2013536","journal-title":"Radiology"},{"issue":"3","key":"9580_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/rlu.0000000000003488","volume":"46","author":"J Morawitz","year":"2021","unstructured":"Morawitz J, Kirchner J, Martin O et al (2021) Prospective correlation of prognostic immunohistochemical markers with SUV and ADC derived from dedicated hybrid breast 18F-FDG PET\/MRI in women with newly diagnosed breast cancer. Clin Nuclear Med 46(3):201\u2013205. https:\/\/doi.org\/10.1097\/rlu.0000000000003488","journal-title":"Clin Nuclear Med"},{"key":"9580_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/RLI.0000000000000177","volume":"50","author":"B G\u00fcckel","year":"2015","unstructured":"G\u00fcckel B, Gatidis S, Enck P et al (2015) Patient comfort during positron emission tomography\/magnetic resonance and positron emission tomography\/computed tomography examinations: subjective assessments with visual analog scales. Invest Radiol 50:726\u2013732","journal-title":"Invest Radiol"},{"key":"9580_CR9","doi-asserted-by":"crossref","unstructured":"Grueneisen J, Sawicki L, Schaarschmidt B et al (2016) Evaluation of a fast protocol for staging lymphoma patients with integrated PET\/MRI. PLoS One 11:e0157880","DOI":"10.1371\/journal.pone.0157880"},{"key":"9580_CR10","doi-asserted-by":"publisher","unstructured":"Grueneisen J, Schaarschmidt B, Heubner M et al (2015) Implementation of FAST-PET\/MRI for whole-body staging of female patients with recurrent pelvic malignancies: a comparison to PET\/CT.  Eur J Radiol. https:\/\/doi.org\/10.1016\/j.ejrad.2015.08.010","DOI":"10.1016\/j.ejrad.2015.08.010"},{"key":"9580_CR11","doi-asserted-by":"crossref","unstructured":"Lindemann ME, Stebner V, Tschischka A, Kirchner J, Umutlu L, Quick HH (2018) Towards fast whole-body PET\/MR: investigation of PET image quality versus reduced PET acquisition times. PLoS One 13:e0206573","DOI":"10.1371\/journal.pone.0206573"},{"key":"9580_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/RLI.0b013e3182823695","volume":"48","author":"V Hartung-Knemeyer","year":"2013","unstructured":"Hartung-Knemeyer V, Beiderwellen KJ, Buchbender C et al (2013) Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography\/magnetic resonance imaging. Invest Radiol 48:290\u2013294","journal-title":"Invest Radiol"},{"key":"9580_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5306\/wjco.v5.i2.61","volume":"5","author":"GL Menezes","year":"2014","unstructured":"Menezes GL, Knuttel FM, Stehouwer BL, Pijnappel RM, van den Bosch MA (2014) Magnetic resonance imaging in breast cancer: a literature review and future perspectives. World J Clin Oncol 5:61\u201370","journal-title":"World J Clin Oncol"},{"key":"9580_CR14","doi-asserted-by":"publisher","unstructured":"Quick H (2014) Integrated PET\/MR. J Magn Reson Imaging. https:\/\/doi.org\/10.1002\/jmri.24523","DOI":"10.1002\/jmri.24523"},{"key":"9580_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.acra.2015.06.004","volume":"22","author":"LJ Grimm","year":"2015","unstructured":"Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS (2015) Abbreviated screening protocol for breast MRI: a feasibility study. Acad Radiol 22:1157\u20131162","journal-title":"Acad Radiol"},{"key":"9580_CR16","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1200\/JCO.2013.52.5386","volume":"32","author":"CK Kuhl","year":"2014","unstructured":"Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB (2014) Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol 32:2304\u20132310","journal-title":"J Clin Oncol"},{"key":"9580_CR17","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.acra.2017.03.014","volume":"24","author":"B Panigrahi","year":"2017","unstructured":"Panigrahi B, Mullen L, Falomo E, Panigrahi B, Harvey S (2017) An abbreviated protocol for high-risk screening breast magnetic resonance imaging: impact on performance metrics and BI-RADS assessment. Acad Radiol 24:1132\u20131138","journal-title":"Acad Radiol"},{"key":"9580_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jacr.2015.08.015","volume":"13","author":"SC Harvey","year":"2016","unstructured":"Harvey SC, Di Carlo PA, Lee B, Obadina E, Sippo D, Mullen L (2016) An abbreviated protocol for high-risk screening breast MRI saves time and resources. J Am Coll Radiol 13:374\u2013380","journal-title":"J Am Coll Radiol"},{"key":"9580_CR19","doi-asserted-by":"publisher","first-page":"20170441","DOI":"10.1259\/bjr.20170441","volume":"91","author":"CK Kuhl","year":"2018","unstructured":"Kuhl CK (2018) Abbreviated breast MRI for screening women with dense breast: the EA1141 trial. Br J Radiol 91:20170441","journal-title":"Br J Radiol"},{"key":"9580_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.diii.2017.01.001","volume":"98","author":"DA Spak","year":"2017","unstructured":"Spak DA, Plaxco JS, Santiago L, Dryden MJ, Dogan BE (2017) BI-RADS\u00ae fifth edition: a summary of changes. Diagn Interv Imaging 98:179\u2013190","journal-title":"Diagn Interv Imaging"},{"key":"9580_CR21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"WM Association","year":"2013","unstructured":"Association WM (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194","journal-title":"JAMA"},{"key":"9580_CR22","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF) (2021) S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms. Version 4.3 AWMF Registernummer: 032-045OL. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/mammakarzinom\/.  Accessed 8 Sept 2022"},{"key":"9580_CR23","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1118\/1.4959546","volume":"43","author":"M Oehmigen","year":"2016","unstructured":"Oehmigen M, Lindemann ME, Lanz T, Kinner S, Quick HH (2016) Integrated PET\/MR breast cancer imaging: attenuation correction and implementation of a 16-channel RF coil. Med Phys 43:4808","journal-title":"Med Phys"},{"key":"9580_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2967\/jnumed.108.054726","volume":"50","author":"A Martinez-M\u00f6ller","year":"2009","unstructured":"Martinez-M\u00f6ller A, Souvatzoglou M, Delso G et al (2009) Tissue classification as a potential approach for attenuation correction in whole-body PET\/MRI: evaluation with PET\/CT data. J Nucl Med 50:520\u2013526","journal-title":"J Nucl Med"},{"key":"9580_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2967\/jnumed.115.156000","volume":"56","author":"DH Paulus","year":"2015","unstructured":"Paulus DH, Quick HH, Geppert C et al (2015) Whole-body PET\/MR imaging: quantitative evaluation of a novel model-based MR attenuation correction method including bone. J Nucl Med 56:1061\u20131066","journal-title":"J Nucl Med"},{"key":"9580_CR26","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1002\/mp.12449","volume":"44","author":"ME Lindemann","year":"2017","unstructured":"Lindemann ME, Oehmigen M, Blumhagen JO, Gratz M, Quick HH (2017) MR-based truncation and attenuation correction in integrated PET\/MR hybrid imaging using HUGE with continuous table motion. Med Phys 44:4559\u20134572","journal-title":"Med Phys"},{"key":"9580_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40644-016-0086-0","volume":"16","author":"J Yan","year":"2016","unstructured":"Yan J, Schaefferkoetter J, Conti M, Townsend D (2016) A method to assess image quality for low-dose PET: analysis of SNR, CNR, bias and image noise. Cancer Imaging 16:26","journal-title":"Cancer Imaging"},{"key":"9580_CR28","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3390\/cancers13122928","volume":"13","author":"L Umutlu","year":"2021","unstructured":"Umutlu L, Kirchner J, Bruckmann N-M et al (2021) Multiparametric integrated 18F-FDG PET\/MRI-based radiomics for breast cancer phenotyping and tumor decoding. Cancers 13:2928","journal-title":"Cancers"},{"key":"9580_CR29","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3390\/cancers14071727","volume":"14","author":"L Umutlu","year":"2022","unstructured":"Umutlu L, Kirchner J, Bruckmann N-M et al (2022) Multiparametric 18F-FDG PET\/MRI-based radiomics for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer. Cancers 14:1727","journal-title":"Cancers"},{"key":"9580_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2967\/jnmt.121.262544","volume":"50","author":"E Nevo","year":"2022","unstructured":"Nevo E, Kamvosoulis P, Currie G (2022) PET\/MRI, part 3: protocols and procedures. J Nucl Med Technol 50:17\u201324","journal-title":"J Nucl Med Technol"},{"key":"9580_CR31","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00330-008-0863-7","volume":"18","author":"RM Mann","year":"2008","unstructured":"Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18:1307\u20131318","journal-title":"Eur Radiol"},{"key":"9580_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jmri.10140","volume":"16","author":"Y Guo","year":"2002","unstructured":"Guo Y, Cai YQ, Cai ZL et al (2002) Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 16:172\u2013178","journal-title":"J Magn Reson Imaging"},{"key":"9580_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/jmri.10116","volume":"15","author":"S Sinha","year":"2002","unstructured":"Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW (2002) In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 15:693\u2013704","journal-title":"J Magn Reson Imaging"},{"key":"9580_CR34","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1007\/s00330-013-2850-x","volume":"23","author":"R Richard","year":"2013","unstructured":"Richard R, Thomassin I, Chapellier M et al (2013) Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol 23:2420\u20132431","journal-title":"Eur Radiol"},{"key":"9580_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.mri.2005.11.005","volume":"24","author":"MD Pickles","year":"2006","unstructured":"Pickles MD, Gibbs P, Lowry M, Turnbull LW (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24:843\u2013847","journal-title":"Magn Reson Imaging"},{"key":"9580_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00330-011-2236-x","volume":"22","author":"SH Park","year":"2012","unstructured":"Park SH, Moon WK, Cho N et al (2012) Comparison of diffusion-weighted MR imaging and FDG PET\/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol 22:18\u201325","journal-title":"Eur Radiol"},{"key":"9580_CR37","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3892\/or.2014.3025","volume":"31","author":"H Iwasa","year":"2014","unstructured":"Iwasa H, Kubota K, Hamada N, Nogami M, Nishioka A (2014) Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography. Oncol Rep 31:1555\u20131560","journal-title":"Oncol Rep"},{"key":"9580_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejrad.2018.08.024","volume":"107","author":"T Igarashi","year":"2018","unstructured":"Igarashi T, Furube H, Ashida H, Ojiri H (2018) Breast MRI for prediction of lymphovascular invasion in breast cancer patients with clinically negative axillary lymph nodes. Eur J Radiol 107:111\u2013118","journal-title":"Eur J Radiol"},{"key":"9580_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0002-9440(10)64757-8","volume":"156","author":"P Auvinen","year":"2000","unstructured":"Auvinen P, Tammi R, Parkkinen J et al (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156:529\u2013536","journal-title":"Am J Pathol"},{"key":"9580_CR40","doi-asserted-by":"publisher","first-page":"A26","DOI":"10.1016\/j.ejrad.2017.05.006","volume":"94","author":"DM Plecha","year":"2017","unstructured":"Plecha DM, Faulhaber P (2017) PET\/MRI of the breast. Eur J Radiol 94:A26\u2013A34","journal-title":"Eur J Radiol"},{"key":"9580_CR41","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2020.0572","volume":"323","author":"CE Comstock","year":"2020","unstructured":"Comstock CE, Gatsonis C, Newstead GM et al (2020) Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening. JAMA 323:746\u2013756","journal-title":"JAMA"},{"key":"9580_CR42","doi-asserted-by":"publisher","first-page":"154.e111","DOI":"10.1016\/j.crad.2020.08.032","volume":"76","author":"R Geach","year":"2021","unstructured":"Geach R, Jones LI, Harding SA et al (2021) The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening: a systematic review and meta-analysis. Clin Radiol 76:154.e111-154.e122","journal-title":"Clin Radiol"},{"key":"9580_CR43","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.acra.2019.05.001","volume":"27","author":"S Choudhery","year":"2020","unstructured":"Choudhery S, Chou SS, Chang K, Kalpathy-Cramer J, Lehman CD (2020) Kinetic analysis of lesions identified on a rapid abridged multiphase (RAMP) breast MRI protocol. Acad Radiol 27:672\u2013681","journal-title":"Acad Radiol"},{"key":"9580_CR44","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1158\/1078-0432.CCR-13-2810","volume":"20","author":"K Pinker","year":"2014","unstructured":"Pinker K, Bogner W, Baltzer P et al (2014) Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study. Clin Cancer Res 20:3540\u20133549","journal-title":"Clin Cancer Res"},{"key":"9580_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2967\/jnumed.106.036780","volume":"48","author":"L Moy","year":"2007","unstructured":"Moy L, Ponzo F, Noz ME et al (2007) Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets. J Nucl Med 48:528\u2013537","journal-title":"J Nucl Med"},{"key":"9580_CR46","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s00330-015-4054-z","volume":"26","author":"D Botsikas","year":"2015","unstructured":"Botsikas D, Kalovidouri A, Becker M et al (2015) Clinical utility of 18F-FDG-PET\/MR for preoperative breast cancer staging. Eur Radiol 26:2297\u20132307","journal-title":"Eur Radiol"},{"key":"9580_CR47","first-page":"369","volume":"16","author":"L Moy","year":"2010","unstructured":"Moy L, Noz ME, Maguire GQ Jr et al (2010) Role of fusion of prone FDG-PET and magnetic resonance imaging of the breasts in the evaluation of breast cancer. Breast J 16:369\u2013376","journal-title":"Breast J"},{"key":"9580_CR48","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/bjc.2017.26","volume":"116","author":"OA Catalano","year":"2017","unstructured":"Catalano OA, Horn GL, Signore A et al (2017) PET\/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype. Br J Cancer 116:893\u2013902","journal-title":"Br J Cancer"},{"key":"9580_CR49","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s00330-013-3037-1","volume":"24","author":"HR Koo","year":"2014","unstructured":"Koo HR, Park JS, Kang KW et al (2014) 18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes. Eur Radiol 24:610\u2013618","journal-title":"Eur Radiol"},{"key":"9580_CR50","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.tranon.2018.11.005","volume":"12","author":"A Surov","year":"2019","unstructured":"Surov A, Meyer HJ, Wienke A (2019) Associations between PET parameters and expression of Ki-67 in breast cancer. Transl Oncol 12:375\u2013380","journal-title":"Transl Oncol"},{"key":"9580_CR51","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12149-012-0579-2","volume":"26","author":"Y Sanli","year":"2012","unstructured":"Sanli Y, Kuyumcu S, Ozkan ZG et al (2012) Increased FDG uptake in breast cancer is associated with prognostic factors. Ann Nucl Med 26:345\u2013350","journal-title":"Ann Nucl Med"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-09580-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T15:11:51Z","timestamp":1691680311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-09580-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["9580"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-09580-6","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"3 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication are Kai Jannusch and Julian Kirchner.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all patients in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 Retrospective\u2022 Diagnostic or prognostic study\u2022 Performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}},{"value":"The funding foundation was not involved in trial design, patient recruitment, data collection, analysis, interpretation or presentation, writing or editing of the reports, or the decision to submit for publication. The corresponding author had full access to all data in the study and had all responsibility for the decision to submit for publication.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}